Merck Research Laboratories, Merck & Co, West Point, Pennsylvania, 19486, USA.
Pharm Res. 2020 Mar 16;37(4):70. doi: 10.1007/s11095-020-2772-7.
While including amorphous solid dispersion (ASD) in tablet formulations is increasingly common, tablets containing high ASD loading are associated with slow disintegration, which presents a challenge to control pill burden for less potent compounds.
We use a model ASD, composed of a hydrophobic drug with copovidone and a non-ionic surfactant, to explore formulation options that can prevent slow disintegration.
In addition to the ASD loading, the pH of the disintegration medium and the inclusion of inorganic salts in the tablet also have an impact on the tablet disintegration time. Certain kosmotropic salts, when added in the formulation, can significantly accelerate tablet disintegration, though the rank order in their effectiveness does not exactly follow the Hofmeister series at pH 1.8. The particle size and dissolution rate of the salt can contribute to its overall effectiveness.
We provided a mechanistic explanation of the disintegration process: fast-dissolving kosmotropic salt results in a concentrated salt solution inside the restrained tablet matrix, thus inhibiting the dissolution of copovidone and preventing polymer gelling which is the main cause leading the slow disintegration. The outcome of this study has enabled the design of a higher ASD loading platform formulation for copovidone based ASD. Graphical Abstract MicroCT aids the mechanistic understanding of the role of inorganic salt in the tablet disintegration of amorphous solid dispersion based formulation.
虽然将无定形固体分散体(ASD)包含在片剂配方中越来越普遍,但含有高 ASD 负载的片剂与缓慢崩解有关,这给控制较弱化合物的丸重带来了挑战。
我们使用一种模型 ASD,由具有共聚维酮和非离子表面活性剂的疏水性药物组成,探索可以防止缓慢崩解的配方选择。
除了 ASD 负载外,崩解介质的 pH 值和片剂中无机盐的包含也会影响片剂崩解时间。某些亲脂性盐在配方中添加时可以显著加速片剂崩解,尽管在 pH 值为 1.8 时其效果的排序并不完全符合豪夫迈斯特系列。盐的粒径和溶解速率有助于其整体效果。
我们对崩解过程提供了一种机制解释:快速溶解的亲脂性盐会在受约束的片剂基质内产生浓缩盐溶液,从而抑制共聚维酮的溶解并防止聚合物胶凝,这是导致缓慢崩解的主要原因。这项研究的结果使我们能够设计更高 ASD 负载平台的共聚维酮基 ASD 配方。
微 CT 有助于了解无机盐在基于无定形固体分散体的制剂片剂崩解中的作用的机制。